TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vitrolife AB
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
316,510
|
290,610
|
164,351 |
Financial expenses |
12,797
|
10,693
|
1,051 |
Earnings before taxes |
-334,535
|
48,255
|
44,976 |
EBITDA |
100,667
|
94,354
|
49,669 |
Total assets |
1,471,611
|
1,846,733
|
1,899,774 |
Current assets |
172,495
|
141,351
|
137,539 |
Current liabilities |
50,198
|
55,804
|
93,315 |
Equity capital |
1,146,539
|
1,503,913
|
1,498,223 |
- share capital |
2,523
|
2,516
|
2,702 |
Employees (average) |
1,084
|
1,117
|
478 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
77.9%
|
81.4%
|
78.9% |
Turnover per employee |
292
|
260
|
344 |
Profit as a percentage of turnover |
-105.7%
|
16.6%
|
27.4% |
Return on assets (ROA) |
-21.9%
|
3.2%
|
2.4% |
Current ratio |
343.6%
|
253.3%
|
147.4% |
Return on equity (ROE) |
-29.2%
|
3.2%
|
3.0% |
Change turnover |
25,054
|
139,572
|
42,558 |
Change turnover % |
9%
|
92%
|
35% |
Chg. No. of employees |
-33
|
639
|
73 |
Chg. No. of employees % |
-3%
|
134%
|
18% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.